Acorda Therapeutics, Inc(NASDAQ:ACOR) 
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Selincro for the treatment of alcohol d...
Website: http://www.acorda.com
Founded: 1995
Full Time Employees: 344
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-10-12
P
O 11.13
H 11.13
L 10.26
C 10.26
V 3,960
10EMA 10.26
20EMA 10.26
60EMA 10.26
120EMA 10.26
250EMA 10.26